Platinum Investment Management’s Aerie Pharmaceuticals AERI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-113,842
Closed -$1.54M 132
2020
Q1
$1.54M Hold
113,842
0.04% 81
2019
Q4
$2.75M Buy
113,842
+11,193
+11% +$232K 0.05% 58
2019
Q3
$1.97M Buy
102,649
+48,265
+89% +$1.11M 0.04% 61
2019
Q2
$1.61M Buy
54,384
+22,684
+72% +$874K 0.04% 74
2019
Q1
$1.51M Hold
31,700
0.04% 79
2018
Q4
$1.14M Hold
31,700
0.04% 71
2018
Q3
$1.95M Sell
31,700
-5,900
-16% -$379K 0.06% 53
2018
Q2
$2.54M Hold
37,600
0.06% 47
2018
Q1
$2.04M Hold
37,600
0.06% 53
2017
Q4
$2.25M Hold
37,600
0.06% 48
2017
Q3
$1.83M Sell
37,600
-4,900
-12% -$267K 0.05% 53
2017
Q2
$2.23M Hold
42,500
0.06% 44
2017
Q1
$1.93M Sell
42,500
-20,200
-32% -$901K 0.05% 50
2016
Q4
$2.37M Sell
62,700
-16,300
-21% -$616K 0.07% 41
2016
Q3
$2.98M Sell
79,000
-43,000
-35% -$948K 0.07% 44
2016
Q2
$2.15M Hold
122,000
0.05% 52
2016
Q1
$1.48M Hold
122,000
0.03% 59
2015
Q4
$2.97M Hold
122,000
0.07% 48
2015
Q3
$2.16M Hold
122,000
0.06% 48
2015
Q2
$2.15M Buy
122,000
+63,000
+107% +$1.15M 0.04% 52
2015
Q1
$1.85M Hold
59,000
0.04% 68
2014
Q4
$1.72M Hold
59,000
0.03% 69
2014
Q3
$1.22M Buy
+59,000
New +$1.16M 0.02% 76

Other funds holding AERI

Platinum Investment Management's AERI Position: Q2 2020 in Review

Platinum Investment Management sold out of Aerie Pharmaceuticals (AERI) in Q2 2020, closing a stake of 113,842 shares — an estimated $1.54M sold.

Platinum Investment Management first reported a position in AERI in Q3 2014 and held it in 23 quarters. The position peaked at $2.98M in Q3 2016. 155 funds tracked by Wall St. Rank hold AERI as of Q2 2020.

  • Platinum Investment Management reported no remaining Aerie Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Platinum Investment Management sold 113,842 Aerie Pharmaceuticals shares in Q2 2020, an estimated $1.54M.
  • Platinum Investment Management first reported a position in Aerie Pharmaceuticals in Q3 2014 and held it in 23 quarters.
  • Platinum Investment Management's Aerie Pharmaceuticals position peaked at $2.98M in Q3 2016.
  • 155 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q2 2020.

Based on Platinum Investment Management's 13F filing for Q2 2020, filed 6 Aug 2020.